Search results
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Vijay Chopra, Dr Deepak Bhatt, Dr Michelle Wong and Dr George L Bakris discuss early intervention and intensive management for CRM disease.
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Scott Isaacs, Prof Peter Rossing, Dr Muthiah Vaduganathan, Prof Stefan Anker and Dr Javed Butler discuss weight management for CRM disease.
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Gerasimos Filippatos, Dr Manisha Sahay, Prof Gianluigi Savarese, Prof Francesco Cosentino and Prof Sam Seidu discuss multidisciplinary implementation strategies.
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Gianluigi Savarese, Dr Alice Cheng, Dr Adeera Levin, Prof Antonio Ceriello, Dr Shelley Zieroth and Prof Giuseppe Rosano discuss managing patients with CRM.
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof John Cleland, Prof Gerasimos Filippatos, Prof Ewa Jankowska, Prof David Wheeler, Dr Kieran Docherty discuss anaemia and iron deficiency.
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Ahmed Bennis, Dr Ileana L Pina, Dr Giulia Ferrannini, Dr Chiadi Ndumele, Prof Rodica Pop-Busui and Prof Mitja Lainscak discuss the epidemiology and pathophysiology of CRM disease.
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Intissar Haddiya, Dr Lars Lund, Prof Marco Metra, Prof Nikolaus Marx, Prof Peter Rossing and Prof Giuseppe Rosano discuss guideline directed therapy for CRM disease.
View more
Added:
7 months ago
AHA Scientific Sessions 2025 - Dr Nils Krüger (Brigham and Women's Hospital, US) joins us to discuss findings from the TIRZSEMA-CVOT (NCT07096063) study, examining real-world cardiovascular outcomes with tirzepatide and semaglutide in patients with type 2 diabetes at cardiovascular risk.This retrospective cohort study utilized three national US claims databases to evaluate over 887,000 patients…
View more
Added:
1 year ago
ERA 2025 - Dr Ellen Linnea Freese Ballegaard (Copenhagen University Hospital, Copenhagen, DK) joins us to discuss a study investigating guideline-based management of CKD and evaluate the associated risk of cardio-renal outcomes. 315,636 patients were identified from nationwide Danish health care registers between 2011 and 2022 and enrolled in the study. The primary outcome measure was a composite…
View more
Added:
1 year ago
ACC 25 - SOUL shows oral semaglutide was superior to placebo in reducing the incidence of 3-point MACE in patients with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease.Late-breaker host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Darren McGuire (UT Southwestern Medical Center, Dallas, US) to discuss the findings from the…
View more